{
    "clinical_study": {
        "@rank": "21812", 
        "acronym": "ROS", 
        "arm_group": [
            {
                "arm_group_label": "no antioxidant  , ROS , pregnancy outcome", 
                "arm_group_type": "Placebo Comparator", 
                "description": "no anti oxidant in the form of ascorbate 1000mg, vitamin E 400, zinc and selenium) will be given to endometriotic women undergoing IVF"
            }, 
            {
                "arm_group_label": "antioxidant , ROS , pregnancy outcome", 
                "arm_group_type": "Active Comparator", 
                "description": "anti oxidant in the form of ascorbate 1000mg, vitamin E 400, zinc and selenium)"
            }
        ], 
        "brief_summary": {
            "textblock": "ROS plays an essential role in the pathogenesis of many reproductive processes. High\n      follicular fluid ROS levels are associated with negative IVF outcomes.\n\n      is plasma level of reactive oxygen species is affected by antioxidant treatment in\n      endometriotic women?"
        }, 
        "brief_title": "Use of Antioxidant in Endometriotic Women to Improve Intracytoplasmic Sperm Injection (ICSI)", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "condition": "Endometriosis", 
        "condition_browse": {
            "mesh_term": "Endometriosis"
        }, 
        "detailed_description": {
            "textblock": "Study design, size, duration: : prospective randomized controlled clinical trial 50 patients\n      with endometriosis diagnosed by US prepared for ICSI were enrolled in the study after\n      consent. they were randomized into 2 groups 25 received antioxidants before starting the\n      protocol , 25 did not receive .  randomization was done by closed envelop single blind for\n      patient Participants/materials, setting, methods: was done in the Egyptian centre for IVF\n      from March 2013 to October 2013 . 50 patients with endometriosis diagnosed by US prepared\n      for ICSI were enrolled in the study after consent. they were randomized into 2 groups 25\n      received antioxidants before starting the protocol , 25 did not receive .  all patients were\n      subjected to plasma sample before start long protocol for induction and second on day of\n      ovum pick up . embryo transfer was done according to embryo grading ."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients with endometriosis\n\n        Exclusion Criteria:\n\n        patients with no endometriosis , not suitable for ICSI-"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "40 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 5, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02058212", 
            "org_study_id": "antioxidants for endometriosis"
        }, 
        "intervention": {
            "arm_group_label": [
                "no antioxidant  , ROS , pregnancy outcome", 
                "antioxidant , ROS , pregnancy outcome"
            ], 
            "description": "anti oxidant in the form of ascorbate 1000mg, vitamin E 400, zinc and selenium) are given to half patients only before IVF , plasma level of ROS are detected before and on day of oocyte retrieval then correlated to pregnancy outcome", 
            "intervention_name": "ascorbate 1000mg, vitamin E 400, zinc and selenium", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Antioxidants", 
                "Selenium", 
                "Vitamin E", 
                "Alpha-Tocopherol", 
                "Tocopherols", 
                "Tocotrienols", 
                "Vitamins"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "ICSI", 
            "antioxidants", 
            "ROS", 
            "endometriosis"
        ], 
        "lastchanged_date": "February 7, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Maadi", 
                        "country": "Egypt", 
                        "zip": "11451"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Maadi", 
                        "country": "Egypt", 
                        "zip": "11451"
                    }, 
                    "name": "egyption centre for IVF"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Maadi", 
                        "country": "Egypt", 
                        "zip": "1"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": "Egypt"
        }, 
        "number_of_arms": "2", 
        "official_title": "Does Antioxidant Supplementation to Endometriotic Women Undergoing ICSI Could Alter Reactive Oxygen Species (ROS) Levels and Affect Pregnancy Outcome", 
        "overall_official": {
            "last_name": "olfat nouh riad, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Egypt: Ministry of Higher Education", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "measure before and 3months    after antioxidant treatment", 
            "measure": "plasma  reactive oxygen species affection by antioxidant treatment", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02058212"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Cairo University", 
            "investigator_full_name": "olfat nouh riad", 
            "investigator_title": "assisstant professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "long protocol administration", 
            "measure": "clinical pregnancy rate", 
            "safety_issue": "No", 
            "time_frame": "2 months"
        }, 
        "source": "Cairo University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cairo University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}